| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Janux Therapeutics, Inc. | Director | Common Stock | 6.23K | $341K | $54.75 | Jul 19, 2024 | Direct |
| XOMA Corp | Director | Common Stock | 3.04K | $42.2K | $13.89 | May 15, 2024 | Direct |
| XOMA Corp | Director | Non-Qualified Share Option (right to buy) | 4.88K | May 15, 2024 | Direct | ||
| Janux Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 4.11K | Jul 19, 2024 | Direct | ||
| ALPINE IMMUNE SCIENCES, INC. | Director | Stock Option (Right to buy) | 0 | May 20, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| JANX | Janux Therapeutics, Inc. | Jul 19, 2024 | 2 | $0 | 4/A | Jul 24, 2024 | Director |
| JANX | Janux Therapeutics, Inc. | Jul 19, 2024 | 4 | $0 | 4 | Jul 22, 2024 | Director |
| JANX | Janux Therapeutics, Inc. | Jul 19, 2024 | 0 | $0 | 3 | Jul 22, 2024 | Director |
| ALPN | ALPINE IMMUNE SCIENCES, INC. | May 20, 2024 | 5 | $0 | 4 | May 20, 2024 | Director |
| XOMA | XOMA Corp | May 15, 2024 | 2 | $0 | 4 | May 17, 2024 | Director |
| ALPN | ALPINE IMMUNE SCIENCES, INC. | Jan 2, 2024 | 1 | $0 | 4 | Jan 4, 2024 | Director |
| XOMA | XOMA Corp | May 17, 2023 | 1 | $0 | 4 | May 19, 2023 | Director |
| ALPN | ALPINE IMMUNE SCIENCES, INC. | Jan 3, 2023 | 1 | $0 | 4 | Jan 5, 2023 | Director |
| XOMA | XOMA Corp | May 18, 2022 | 1 | $0 | 4 | May 20, 2022 | Director |
| ALPN | ALPINE IMMUNE SCIENCES, INC. | Jan 3, 2022 | 1 | $0 | 4 | Jan 4, 2022 | Director |
| XOMA | XOMA Corp | May 19, 2021 | 1 | $0 | 4 | May 21, 2021 | Director |